Programme WEDNESDAY, 14 FEBRUARY 2018
IMAGING COURSE
08:30 Imaging intermediate AMD and subclinical neovascularization
08:50 Different CNV types by OCT-A and evaluation of their activity without use of fluorescein angiography
09:10 “Smart-check” of the imaging to assess the response to AMD treatment
09:30 OCT-A findings of PCV and changes under treatment
09:50 OCT-A findings in CSCR, CNV in CSCR, Mactel I and II
10:10 Clinical value of the imaging assessment of the choroid
10:30 COFFEE BREAK
11:00 Peculiar characteristics of myopic CNV on OCT-A and assessment of response to anti-VEGF treatment
11:20 Managing irvine-gass: OCT assessment of macula prior and after cataract surgery and response to treatment
11:40 Challenges in interpretation of OCT-A images in AMD
DME IN REAL LIFE
12:00 New aspects of biomicroscopic modification of macular stroma and vascularization in the progression of ME
12:30 Correlation of inflammation biomarkers and the stage of ME
13:00 LUNCH
14:00 DME in imaging and OCT/OCT-A: what is important to know
14:30 Intravitreal steroids: biological and clinical differences
15:00 COFFEE BREAK
15:30 Real life data of DME intravitreal treatments and patients management
16:00 – 16:30 Intravitreal treatment: burden for patients and payers